CN102671022B - Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps - Google Patents
Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps Download PDFInfo
- Publication number
- CN102671022B CN102671022B CN201210155270.0A CN201210155270A CN102671022B CN 102671022 B CN102671022 B CN 102671022B CN 201210155270 A CN201210155270 A CN 201210155270A CN 102671022 B CN102671022 B CN 102671022B
- Authority
- CN
- China
- Prior art keywords
- percent
- soup
- radix
- heat
- honeysuckle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000014347 soups Nutrition 0.000 title claims abstract description 11
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 title claims abstract description 8
- 208000005647 Mumps Diseases 0.000 title abstract description 12
- 208000010805 mumps infectious disease Diseases 0.000 title abstract description 12
- 244000068988 Glycine max Species 0.000 title abstract description 8
- 235000010469 Glycine max Nutrition 0.000 title abstract description 8
- 230000009967 tasteless effect Effects 0.000 title abstract description 8
- 241000205585 Aquilegia canadensis Species 0.000 title abstract 3
- 235000014676 Phragmites communis Nutrition 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 17
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 241000255791 Bombyx Species 0.000 claims description 5
- 241000959626 Calvatia Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000010231 banlangen Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000008961 swelling Effects 0.000 abstract description 11
- 208000011580 syndromic disease Diseases 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000003681 parotid gland Anatomy 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 201000000297 Erysipelas Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010014599 encephalitis Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 241000711386 Mumps virus Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 201000011475 meningoencephalitis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 201000005737 orchitis Diseases 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034023 Parotid gland enlargement Diseases 0.000 description 1
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000612119 Samolus Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003481 parotid region Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003670 sublingual gland Anatomy 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of Chinese medicament formulas, and in particular relates to honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps. The soup is characterized by comprising the following raw medicaments in percentage by weight: 12 to 16 percent of honeysuckle, 9 to 12 percent of weeping forsythiae, 6 to 9 percent of fructus arctii, 5 to 9 percent of tasteless preserved soybean, 9 to 13 percent of reed rhizome, 6 to 9 percent of platycodon grandiflorum, 3 to 6 percent of mint, 5 to 7 percent of schizonepeta spike, 5 to 7 percent of isatis root, 3 to 5 percent of bupleurum, 3 to 6 percent of lophantherum gracile, 3 to 6 percent of licorice, 3 to 6 percent of astragalus root, 2 to 5 percent of coptis root, 2 to 4 percent of stiff silkworm, and 3 to 5 percent of puffball seed. The 16 raw medicaments are soaked into water and decocted, residue is removed, and filtrate is obtained. The soup is low in cost and high in curative effect of treating the mumps, does not have toxic or side effect, has the effects of dispelling wind, clearing heat, detoxifying, eliminating swelling and removing stasis, is suitable for epidemic heat syndrome and heat toxin blocked channel syndrome and the like, and does not cause sequela and complication after healing.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, be specifically a kind ofly used for the treatment of parotitic Jin Lianniu Radix Sophorae Tonkinensis soup.
Background technology
As everyone knows, mumps is by the caused Acute respiratory infectious disease of mumps virus.Take parotid gland nonsuppurative inflammation, parotid region swells and ache as Clinical symptoms, mainly occurs in child and teenager.Mumps virus, except invading the parotid gland, still can be invaded nervous system and various gland tissue, causes meningitis, meningoencephalitis, orchitis, oophoritis and pancreatitis etc.After falling ill 1～2 day, there is the jugal bridge or ear's pain in patient, sialosis then, and body temperature rise can reach 40 ℃.The parotid gland is the most often got involved, and after a common side parotid gland enlargement, within 2-4 days, involves again offside.Orifice of parotid duct often has redness in early days, and submaxillary gland or sublingual gland can be got involved simultaneously, swelling under visible Sublingual and throat jaw, and there is dysphagia.Meningoencephalitis or Patients With Encephalitis often have high heat, delirium, tic, stupor, and serious symptom person can lethally die.Can leave over the sequela such as deafness, visual disorder.Although major lesions is at the parotid gland, mumps is actually a kind of systemic infection, can involve central nervous system or other bodies of gland, corresponding Sx appears in organ.Clinical treatment is mainly anti symptom treatment, and headache and swelling of parotid gland can be applied analgesic, antiviral therapy and application hormone, and price and side effect are large, to patient, have brought great economy and mental burden.
Summary of the invention
Object of the present invention is exactly in order to overcome above-mentioned existing technical deficiency, a kind of parotitic Jin Lianniu Radix Sophorae Tonkinensis soup that is used for the treatment of is provided, cost is low, treatment parotitis curative effect is high, have no side effect, there is the effect of wind and heat dispersing removing toxic substances, dispersing swelling and dissipating binds, be applicable to warm drug-pedlar's table, pyretic toxicity accumulates the syndromes such as network, does not stay sequela and complication after more.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind ofly treat parotitic Jin Lianniu Radix Sophorae Tonkinensis soup, it is characterized in that: crude drug composition is by weight percentage, Flos Lonicerae 12～16%, Fructus Forsythiae 9～12%, Fructus Arctii 6～9%, tasteless preserved soybean 5～9%, Rhizoma Phragmitis 9～13%, Radix Platycodonis 6～9%, Herba Menthae 3～6%, Herba Schizonepetae 5～7%, Radix Isatidis 5～7%, Radix Bupleuri 3～5%, Herba Lophatheri 3～6%, Radix Glycyrrhizae 3～6%, the Radix Astragali 3～6%, Rhizoma Coptidis 2～5%, Bombyx Batryticatus 2～4%, Lasiosphaera Seu Calvatia 3～5%, above-mentioned 16 taste crude drug are soaked, the filtrate of removing slag after decocting to obtain.
The invention has the beneficial effects as follows, cost is low, and treatment parotitis curative effect is high, has no side effect, and has the effect of wind and heat dispersing removing toxic substances, dispersing swelling and dissipating binds, is applicable to warm drug-pedlar's table, and pyretic toxicity accumulates the syndromes such as network, does not stay sequela and complication after more.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Adopt Flos Lonicerae, Fructus Forsythiae, Fructus Arctii, tasteless preserved soybean, Rhizoma Phragmitis, Radix Platycodonis, Herba Menthae, Herba Schizonepetae, Radix Isatidis, Radix Bupleuri, Herba Lophatheri, Radix Glycyrrhizae, the Radix Astragali, Rhizoma Coptidis, Bombyx Batryticatus, Lasiosphaera Seu Calvatia to be prepared from for crude drug.Every pair of its component (% by weight) is Flos Lonicerae 13.7, Fructus Forsythiae 10.3, Fructus Arctii 8.2, tasteless preserved soybean 8.1, Rhizoma Phragmitis 10.3, Radix Platycodonis 8.2, Herba Menthae 4.1, Herba Schizonepetae 6.3, Radix Isatidis 6.2, Radix Bupleuri 4.1, Herba Lophatheri 3.9, Radix Glycyrrhizae 4.1, the Radix Astragali 3.9, Rhizoma Coptidis 3.4, Bombyx Batryticatus 2.1, Lasiosphaera Seu Calvatia 3.1.Getting above-mentioned 16 taste raw material gross weights is 146 grams, first Herba Menthae is wrapped separately, the 15 kinds of raw materials of Yuing add water to 900～1000ml, water covers powder, soak 2～3 hours, effective ingredient is easy to fried, then boil with high heat again and slowly decoct 30 minutes with slow fire, again Herba Menthae is poured into, decoct about 10 minutes, the filtrate 150ml left and right of removing slag to obtain, medicinal residues add water 200～300ml again, decoct 15～20 minutes, filtrate 50～the 70ml that removes slag to obtain, to obtain 200～220ml left and right medicinal liquid altogether, makes Jin Lianniu Radix Sophorae Tonkinensis soup, pack in aseptic vial, seal bottle cap is standby.Every day potion divide 2 times oral, each (medicine) being taken before meal 100～110ml; When New Oral Gold connects cattle Radix Sophorae Tonkinensis soup, coordinate again with 30 grams of Flos Chrysanthemi Indicis, 30 grams, Semen Phaseoli powder, first wild chrysanthemum leaf is mashed as mud shape, add Semen Phaseoli powder to be in harmonious proportion evenly, with Ovum Gallus domesticus album furnishing pasty state, be applied to the affected part of swelling and ache outward, cover nontoxic preservative film, fixing with applying ointment or plaster again, change dressings every day once, disappear completely to clinical symptoms signs such as cheek swell and ache.Fb dur, should encourage to lie up, and avoids occurring parotid gland encephalitis, the complication such as orchitis, and diet be take liquid, semi-fluid as main, and patient is isolated.
In principal agent Flos Lonicerae of the present invention, contain the flavones ingredients such as chlorogenic acid tetrem acyl compound, this brookweed element, volatile oil, triterpene saponin and a small amount of inositol etc.Flos Lonicerae has inhibitory action to staphylococcus aureus, Hemolytic streptococcus, Bacillus typhi, escherichia coli, meningococcus, tubercule bacillus, bacillus pyocyaneus and influenza virus, herpesvirus etc.Studies have shown that, chlorogenic acid and isochlorogenic acid are its effective antimicrobial components, and its decoct is diluted to the concentration of 1: 1280, still can promote leukocytic phagocytic function.Nature and flavor are sweet, cold, return lung, the heart, stomach warp, have the function of heat-clearing and toxic substances removing, wind-heat dissipating, for carbuncle furuncle, sore throat, erysipelas, toxic-heat and blood stasis, anemopyretic cold, epidemic febrile disease heating.Fructus Forsythiae, containing phillyrin, Fructus Forsythiae aglycon, Fructus Forsythiae fat glycosides A, B, C, D, ursolic acid, oleanolic acid etc., separately, containing volatile oil, is mainly present in seed.Fructus Forsythiae has a broad antifungal spectrum, bacteriostasis in vitro and Flos Lonicerae broadly similar, its antibiotic effective ingredient is Fructus Forsythiae fat glycosides A, B, C, D.Nature and flavor are bitter, are slightly cold, and return lung, the heart, small intestine meridian.The function with heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, for carbuncle, scrofula, acute mastitis, erysipelas, anemopyretic cold, epidemic febrile disease is from the beginning of, warm joining the army, high hot excessive thirst, coma is sent out speckle, pyretic stranguria urine retention.Fructus Arctii decocting liquid has inhibitory action to hemolytic staphylococcus aureus, to animal diuresis slightly.Nature and flavor are pungent, bitter, cold, attach to the lung and stomach meridians.There are expelling wind and cold pathogens, lung qi dispersing rash, the function of resolving toxin and disinhibiting the throat, for anemopyretic cold, cough with copious phlegm, measles, rubella, laryngopharynx swelling and pain, mumps erysipelas, carbuncle bleb poison.Tasteless preserved soybean nature and flavor are bitter, pungent, cool, attach to the lung and stomach meridians.Have induce sweat, relieving restlessness, a surname send out hot and suffocating, for flu, cold and heat, headache, irritated uncomfortable in chest, restlessness of asrhenia type and insomnia.Rhizoma Phragmitis nature and flavor are sweet, cold, attach to the lung and stomach meridians.The function with clearing away heat and promoting production of body fluid, relieving restlessness, emesis, diuresis, for calentura excessive thirst, the gastric heat sound of vomiting of vomitting, cough due to lung-heat, lung abscess vomiting pus, the puckery pain of pyretic stranguria.Radix Platycodonis nature and flavor are bitter, pungent, flat, return lung meridian.There is lung qi dispersing, sore-throat relieving, eliminate the phlegm, the function of evacuation of pus, for cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.Herba Menthae nature and flavor are pungent, cool, return lung, Liver Channel.The function with dispelling wind-heat, refresh oneself, rash, for anemopyretic cold, pathogenic wind-warm is from the beginning of, headache, conjunctival congestion, sore throat, aphtha, rubella, measles, breast side of body feeling of distension and oppression.Herba Schizonepetae nature and flavor are pungent, tepor, return lung, Liver Channel.The function with induce sweat loose wind, rash, for flu, headache, measles, rubella, skin infection is bitter, cold from the beginning of, Radix Isatidis nature and flavor, GUIXIN, stomach warp.The function with heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving, for maculae caused by violent heat pathogen, crimson tongue is purple dark, mumps, larynx addiction, scarlet fever, major part pestilence, erysipelas, carbuncle.Radix Bupleuri nature and flavor are bitter, be slightly cold, and return liver, gallbladder meridian.The function with reconciling superficies and interior, soothing the liver, yang invigorating, for cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium etc.Herba Lophatheri nature and flavor are sweet, light, cold, GUIXIN, stomach, small intestine meridian.The function with clearing heat and relieving fidgetness, diuresis, for calentura excessive thirst, hot urination drenches pain, aphtha of the mouth and tongue.Radix Glycyrrhizae nature and flavor are sweet, flat, GUIXIN, lung, spleen, stomach warp, the function with invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.Radix Astragali nature and flavor are sweet, warm, return lung, spleen channel.The function with invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, carbuncle is difficult bursts, and bursts and does not hold back for a long time, deficiency of vital energy edema etc.Rhizoma Coptidis nature and flavor are bitter, cold, GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel.The function with heat clearing and damp drying, eliminating fire and detoxication, for damp and hot feeling of fullness, vomiting acid regurgitation, unconsciousness due to high fever, hyperactivity of heart-fire, heat in blood is told nosebleed, conjunctival congestion, toothache, quenches one's thirst, carbuncle skin ulcer furuncle etc.Bombyx Batryticatus nature and flavor are salty, pungent, flat, return lung, liver, stomach warp.The function with expelling wind for relieving convulsion, dissipating phlegm and resolving masses, for convulsion with spasms, laryngopharynx swelling and pain, skin pruritus, submandibular lymph nodes is scorching, facial paralysis etc.Lasiosphaera Seu Calvatia nature and flavor are pungent, flat, return lung meridian.The function with removing heat from the lung and relieving sorethroat, hemostasis.For the strongly fragrant lung of wind heat, pharyngalgia, cough, hoarseness etc.Flos Lonicerae, Fructus Forsythiae relieving the exterior syndrome with drugs of pungent in flavor and cool in nature in agent in this, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, cures mainly various virus, and carbuncle furuncle swells as dispelling wind and heat pathogens such as monarch drug, Herba Menthae, Fructus Arctiis, resolving toxin and disinhibiting the throat, Herba Schizonepetae, tasteless preserved soybean is pungent and tepor, and principal drug assistance a surname is dispersed in the heresy of table, is ministerial drug altogether.The clearing away heat and promoting production of body fluid such as Rhizoma Phragmitis, Herba Lophatheri, Radix Platycodonis, Radix Glycyrrhizae, sore-throat relieving reduces phlegm, Wei Zuo Lai medicine.16 kinds of ingenious prescriptions of Chinese herbal medicine, the mutual coordinative role of medicine, plays the specially good effect of mumps altogether.
The embodiment that each raw material of the present invention also can the listed ratio of according to the form below (percentage by weight) mixes realizes, and its processing method is identical with embodiment mono-.
Below in conjunction with my institute, the clinical trial that Wendeng City, In Shandong Weihai central hospital carries out is done further, is described in detail the present invention:
1. case selection: this organizes 60 examples, according to Yang Shaoji, Ren Hong chief editor < < lemology > > " mumps " diagnostic criteria, selects 60 examples.Male 29 examples wherein, female's 31 examples; 3～8 years old 36 examples.9～15 years old 16 examples, 16 years old above 8 example.
2. Therapeutic Method: every day potion divide 2 times oral, each (medicine) being taken before meal 100～110ml; The oral while, then coordinate with 30 grams of Flos Chrysanthemi Indicis, 30 grams, Semen Phaseoli powder, first wild chrysanthemum leaf is mashed as mud shape, add Semen Phaseoli powder to be in harmonious proportion evenly, with Ovum Gallus domesticus album furnishing pasty state, be applied to the affected part of swelling and ache outward, cover nontoxic preservative film, fixing with applying ointment or plaster again, change dressings every day once, treat altogether 7 days.
3. the standard of curative effect evaluation: cure: treat 3～7 days, mumps disappears completely, high heat, has a headache, and the clinical symptoms signs such as inappetence disappear completely; Effective: treatment treatment 3～7 days, mumps partly disappears, and the clinical symptoms signs such as high heat, headache, inappetence partly disappear; Invalid: mumps is without disappearing, and clinical symptoms sign is without change.
4. therapeutic outcome: use the present invention to treat 60 examples, application the standard of curative effect evaluation carries out therapeutic outcome evaluation, cures 52 examples, effective 6 examples, invalid 2 examples, total effective rate is 96.7%.
Claims (1)
1. treat parotitic Jin Lianniu Radix Sophorae Tonkinensis soup for one kind, it is characterized in that: crude drug composition is by weight percentage, Flos Lonicerae 12～16%, Fructus Forsythiae 9～12%, Fructus Arctii 6～9%, Semen Sojae Preparatum 5～9%, Rhizoma Phragmitis 9～13%, Radix Platycodonis 6～9%, Herba Menthae 3～6%, Herba Schizonepetae 5～7%, Radix Isatidis 5～7%, Radix Bupleuri 3～5%, Herba Lophatheri 3～6%, Radix Glycyrrhizae 3～6%, the Radix Astragali 3～6%, Rhizoma Coptidis 2～5%, Bombyx Batryticatus 2～4%, Lasiosphaera Seu Calvatia 3～5%, above-mentioned 16 taste crude drug are soaked to the filtrate of removing slag to obtain after decocting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210155270.0A CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210155270.0A CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102671022A CN102671022A (en) | 2012-09-19 |
| CN102671022B true CN102671022B (en) | 2014-07-16 |
Family
ID=46804006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210155270.0A Active CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102671022B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908735B (en) * | 2014-03-04 | 2015-09-30 | 太仓市伟基生物科技有限公司 | A kind of gauze type Chinese medicine headgear preventing and treating mumps |
| CN103933396A (en) * | 2014-04-22 | 2014-07-23 | 湖州康企药业有限公司 | Heat-clearing toxicity-removing oral solution |
| CN104721296A (en) * | 2015-04-03 | 2015-06-24 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine used for treating parotitis |
| CN105395957A (en) * | 2015-12-31 | 2016-03-16 | 张明 | Traditional Chinese medicine composition for treating livestock mumps |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1473604A (en) * | 2003-08-08 | 2004-02-11 | 冉光奇 | Capsule for treating epidemic parotitis |
-
2012
- 2012-05-08 CN CN201210155270.0A patent/CN102671022B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1473604A (en) * | 2003-08-08 | 2004-02-11 | 冉光奇 | Capsule for treating epidemic parotitis |
Non-Patent Citations (2)
| Title |
|---|
| 刘绍贵主编.羚羊感冒胶囊.《中药处方手册》.湖南科学技术出版社,2003,382. * |
| 林才生,宋士山主编.小儿流行性腮腺炎.《中医临床专验良方3300首》.中国中医药出版社,1998,396. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102671022A (en) | 2012-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102671022B (en) | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN103830636A (en) | Pharmaceutical composition for treating bronchitis and asthma | |
| CN103610885B (en) | Traditional Chinese medicine preparation for treating rash | |
| CN104784548A (en) | Traditional Chinese medicine composition for treating cough and application thereof | |
| CN103751638A (en) | Acne damp-clearing complexing agent and preparation method thereof | |
| CN104257778B (en) | A kind of Chinese medicine treating rheumatic arthritis | |
| CN103505530B (en) | Traditional Chinese medicine composition for treating variability measles | |
| CN104161878A (en) | Traditional Chinese medicine preparation for treating lung abscess | |
| CN102727738A (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof | |
| CN103610892A (en) | Traditional Chinese medicine powder for treating dental ulcers | |
| CN103566248B (en) | The Chinese medicine for the treatment of mumps | |
| CN104784394A (en) | Traditional Chinese medicine sachet with capability of improving immunity and preparation method of traditional Chinese medicine sachet | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN103463444B (en) | Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN102125620B (en) | Traditional Chinese medicinal preparation for treating erysipelas | |
| CN105169324A (en) | Chinese herba preparation for prevention and treatment of common cold due to wind-cold | |
| CN104383325A (en) | Oral liquid for treating amygdalitis | |
| CN104771498A (en) | Traditional Chinese medicine composition for treating mumps caused by accumulated toxic heat | |
| CN104474154A (en) | Traditional Chinese medicine for treating cold fever and preparation method of traditional Chinese medicine | |
| CN104398724A (en) | Preparation method for traditional Chinese medicine preparation treating pemphigus | |
| CN103989885A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation | |
| CN103800890A (en) | Medicine for treating menoxenia and preparation method thereof | |
| CN104666454A (en) | Plaster for preventing and treating deficiency-type carbuncle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG LIHUA Free format text: FORMER OWNER: YU LIHUA Effective date: 20141224 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264400 WEIHAI, SHANDONG PROVINCE TO: 637400 NANCHONG, SICHUAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141224 Address after: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee after: Wang Lihua Address before: 264400 Wendeng, Shandong, Zhejiang Province, East Hill Road, No. 3, Wendeng Central Hospital, Weihai Patentee before: Yu Lihua |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151224 Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee before: Wang Lihua |
|
| CP01 | Change in the name or title of a patent holder |
Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee after: Suzhong Pharmaceutical Group Co.,Ltd. Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder |